| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3625774 | B | Inhibition of human KV1.5 expressed in mouse L929 cells assessed as decrease in ultrarapid potassium current amplitude | Homo sapiens | 24 | cell-based format | Scientific Literature | ||
| 2. | ALA3625776 | A | Metabolic stability in human liver microsomes assessed as compound remaining at 3 uM after 10 mins | Homo sapiens | 24 | assay format | Scientific Literature | ||
| 3. | ALA3625777 | A | Metabolic stability in rat liver microsomes assessed as compound remaining at 3 uM after 10 mins | Rattus norvegicus | 24 | assay format | Scientific Literature | ||
| 4. | ALA3625778 | A | Metabolic stability in mouse liver microsomes assessed as compound remaining at 3 uM after 10 mins | Mus musculus | 24 | assay format | Scientific Literature | ||
| 5. | ALA3625779 | B | Inhibition of calcium channel (unknown origin) at 10 uM relative to control | Homo sapiens | 5 | assay format | Scientific Literature | ||
| 6. | ALA3625780 | B | Inhibition of sodium channel (unknown origin) at 10 uM relative to control | Homo sapiens | 5 | assay format | Scientific Literature | ||
| 7. | ALA3625781 | B | Inhibition of human ERG at 10 uM relative to control | Homo sapiens | 5 | single protein format | Scientific Literature | ||
| 8. | ALA3625782 | A | Cmax in rat at 2 mg/kg administered as intra-arterial infusion for 10 mins and 5 mg/kg, po | Rattus norvegicus | 2 | organism-based format | Scientific Literature | ||
| 9. | ALA3625783 | A | AUC in rat at 5 mg/kg, po | Rattus norvegicus | 2 | organism-based format | Scientific Literature | ||
| 10. | ALA3625784 | A | Half life in rat at 2 mg/kg administered as intra-arterial infusion for 10 mins and 5 mg/kg, po | Rattus norvegicus | 2 | organism-based format | Scientific Literature | ||
| 11. | ALA3625785 | A | Clearance in rat at 2 mg/kg administered as intra-arterial infusion for 10 mins and 5 mg/kg, po | Rattus norvegicus | 2 | organism-based format | Scientific Literature | ||
| 12. | ALA3625786 | A | Volume of distribution at steady state in rat at 2 mg/kg administered as intra-arterial infusion for 10 mins and 5 mg/kg, po | Rattus norvegicus | 2 | organism-based format | Scientific Literature | ||
| 13. | ALA3625787 | A | Oral bioavailability in rat at 5 mg/kg | Rattus norvegicus | 2 | organism-based format | Scientific Literature | ||
| 14. | ALA3625794 | B | Inhibition of rat muscarinic acetylcholine receptor at 10 uM relative to control | Rattus norvegicus | 2 | assay format | Scientific Literature | ||
| 15. | ALA3625795 | F | Induction of QT interval prolongation in rat at 3 mg/kg, iv administered as infusion for 5 mins by ECG analysis | Rattus norvegicus | 3 | organism-based format | Scientific Literature | ||
| 16. | ALA3625796 | T | Toxicity in rat assessed as increase in blood pressure at 3 mg/kg, iv administered as infusion for 5 mins | Rattus norvegicus | 3 | organism-based format | Scientific Literature | ||
| 17. | ALA3625928 | A | Plasma concentration in rat at 3 mg/kg, iv administered as infusion for 5 mins | Rattus norvegicus | 3 | organism-based format | Scientific Literature | ||
| 18. | ALA3625929 | F | Induction of arterial effective refractory period prolongation in rabbit | Oryctolagus cuniculus | 3 | organism-based format | Scientific Literature | ||
| 19. | ALA3625930 | T | Toxicity in rabbit assessed as effect on ventricular effective refractory period | Oryctolagus cuniculus | 3 | organism-based format | Scientific Literature | ||
| 20. | ALA3625931 | T | Toxicity in rabbit assessed as increase in gastrointestinal motility | Oryctolagus cuniculus | 1 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!